NexgenRx Valuation
Is NXG undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NXG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate NXG's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate NXG's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NXG?
Key metric: As NXG is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is NXG's PS Ratio? | |
|---|---|
| PS Ratio | 1.4x |
| Sales | CA$15.34m |
| Market Cap | CA$20.98m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.4x |
| Enterprise Value/EBITDA | 15.4x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does NXG's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.8x | ||
ENA Ensurance | 7x | n/a | AU$24.3m |
TBK Transilvania Broker de Asigurare | 0.7x | n/a | RON 79.8m |
YOLO Yolo Group | 1.5x | 50.4% | €14.5m |
ASN ASN Broker | 2.1x | n/a | ฿338.8m |
NXG NexgenRx | 1.4x | n/a | CA$21.0m |
Price-To-Sales vs Peers: NXG is good value based on its Price-To-Sales Ratio (1.4x) compared to the peer average (1.4x).
Price to Sales Ratio vs Industry
How does NXG's PS Ratio compare vs other companies in the North American Insurance Industry?
| 10 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 10 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: NXG is expensive based on its Price-To-Sales Ratio (1.4x) compared to the North American Insurance industry average (1.1x).
Price to Sales Ratio vs Fair Ratio
What is NXG's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.4x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate NXG's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Definity Financial
CA$6.4b
Offers property and casualty insurance products in Canada.
DFY
CA$56.93
7D
3.5%
1Y
51.1%
iA Financial
CA$12.3b
Provides insurance and wealth management services in Canada and the United States.
IAG
CA$131.52
7D
2.6%
1Y
48.8%
Sagicor Financial
CA$838.1m
Provides insurance products and related financial services in Jamaica, Barbados, Trinidad, Tobago, other Caribbean region, and the United States.
SFC
CA$6.04
7D
-0.2%
1Y
-0.7%